Stimulant-Involved Cardiovascular Disease Mortality and Life Years Lost, 2014 to 2023
Stimulant-involved CVD mortality has surged, especially among non-Hispanic American Indian/Alaska Native and non-Hispanic White populations and older adults, with cerebrovascular disease showing the largest increase among CVD subtypes. The findings reveal the importance of targeted prevention, screening, and intervention.
Authors
- Dana A. Glei (ORCID: https://orcid.org/0000-0002-2865-9355)
- Rebecca Arden Harris (ORCID: https://orcid.org/0000-0001-6058-0463)
- Judith A. Long (ORCID: https://orcid.org/0000-0003-4748-181X)
- Sameed Ahmed M. Khatana (ORCID: https://orcid.org/0000-0002-1345-3004)
Institutions
- Georgetown University (US)
- Cardiovascular Institute of the South (US)
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Substance Use Research and Treatment
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1177/29768357251342744
- Citations
- 1
- Primary Topic
- Forensic Toxicology and Drug Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- National Heart, Lung, and Blood Institute
- National Institute on Drug Abuse